Unveiling Wilson Disease: Recurrent Seizures as an Initial Presentation
DOI:
https://doi.org/10.59652/0rdjg184Keywords:
Wilson disease, ATP7B, seizures, intention tremor, Kayser-Fleischer rings, copper metabolism.Abstract
Wilson disease is an autosomal recessive disorder caused by pathogenic variants in ATP7B, resulting in impaired copper excretion and progressive copper accumulation in the liver, brain, cornea, and other tissues. Neurologic disease more commonly presents with movement abnormalities, whereas seizures are an uncommon initial manifestation. We report a 32-year-old man with a 2-year history of recurrent generalized tonic-clonic seizures, followed by intention tremor, dysarthria, gait disturbance, and hypersalivation. Serum ceruloplasmin was markedly reduced (6 mg/dL), 24-hour urinary copper excretion was elevated (321 µg/24 h), Kayser-Fleischer rings were present, and brain MRI showed bilateral basal ganglia and midbrain hyperintensities. A Leipzig score of 8 supported the diagnosis of Wilson disease. Treatment with D-penicillamine, zinc acetate, pyridoxine, dietary copper restriction, and levetiracetam was associated with cessation of seizures and improved functional independence over six months. Wilson disease should be considered in young adults with unexplained recurrent seizures accompanied by progressive movement abnormalities or encephalopathy.
Downloads
References
1. Rayana S, Kamba BM, Yarraguntla K, Haritha G, Chigurupati D. A case report on Wilson’s disease. J Young Pharm. 2023;15(2):384-386. doi:10.5530/jyp.2023.15.52.
2. Mills B, Baker AL, Whitney EC. A case study on Wilson disease. J Diagn Med Sonogr. 2014;30(1):30-33. doi:10.1177/8756479313517765.
3. Rasib AR, Aziz Jabarkhil A, Sediqi MF, Mansoor AI, Asady A. Wilson’s disease presenting with generalized tonic-clonic seizure and cerebellar dysfunction. Int Med Case Rep J. 2021;14:529-532. doi:10.2147/IMCRJ.S320639.
4. Brůha R, Mareček Z, Martásek P, Nevšímalová S, Petrtýl J, Urbánek P, et al. Wilsonova choroba [Wilson’s disease]. Cas Lek Cesk. 2009;148(11):544-548.
5. Hlubocká Z, Mareček Z, Linhart A, Kejřová E, Pospíšilová L, Martásek P, et al. Cardiac involvement in Wilson disease. J Inherit Metab Dis. 2002;25(4):269-277. doi:10.1023/A:1016546223327.
6. Datta AK, Mukherjee A, Chaudhuri J, Pandit A, Gangopadhyay G. Not the stereotypical Wilson disease: a case report. Tremor Other Hyperkinet Mov (N Y). 2021;11:44. doi:10.5334/tohm.658.
7. Kurlan RM, Greene PE, Biglan KM. Hyperkinetic movement disorders. Oxford: Oxford University Press; 2015. doi:10.1093/med/9780199925643.001.0001.
8. Członkowska A, Litwin T, Chabik G. Wilson disease: neurologic features. Handb Clin Neurol. 2017;142:101-119. doi:10.1016/B978-0-444-63625-6.00010-0.
9. Dening TR, Berrios GE, Walshe JM. Wilson’s disease and epilepsy. Brain. 1988;111(Pt 5):1139-1155. doi:10.1093/brain/111.5.1139.
10. Liu J, Luan J, Zhou X, Cui Y, Han J. Epidemiology, diagnosis, and treatment of Wilson’s disease. Intractable Rare Dis Res. 2017;6(4):249-255. doi:10.5582/irdr.2017.01057.
11. Frota NAF, Caramelli P, Barbosa ER. Cognitive impairment in Wilson’s disease. Dement Neuropsychol. 2009;3(1):16-21. doi:10.1590/S1980-57642009DN30100004.
12. Leelamani V, George J. Rare initial presentation of Wilson’s disease as acute encephalopathy with recurrent seizure. Oman Med J. 2023;38(2):e492. doi:10.5001/omj.2023.17.
13. Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47(6):2089-2111. doi:10.1002/hep.22261.
14. Ferenci P. Pathophysiology and clinical features of Wilson disease. Metab Brain Dis. 2004;19(3-4):229-239. doi:10.1023/B:MEBR.0000043973.10494.85.
15. Kalita J, Misra UK, Kumar V, Parashar V. Predictors of seizure in Wilson disease: a clinico-radiological and biomarkers study. Neurotoxicology. 2019;71:87-92. doi:10.1016/j.neuro.2018.12.005.
16. Shorvon SD. Introduction to the concept of symptomatic epilepsy. In: Shorvon SD, Andermann F, Guerrini R, editors. The causes of epilepsy: common and uncommon causes in adults and children. Cambridge: Cambridge University Press; 2011. p. 113-118. doi:10.1017/CBO9780511921001.016.
17. Sinha S, Taly AB, Ravishankar S, Prashanth LK, Venugopal KS, Arunodaya GR, et al. Wilson’s disease: cranial MRI observations and clinical correlation. Neuroradiology. 2006;48(9):613-621. doi:10.1007/s00234-006-0101-4.
18. Pfeiffer RF. Wilson disease. Continuum (Minneap Minn). 2016;22(4 Movement Disorders):1246-1261. doi:10.1212/CON.0000000000000350.
19. Woimant F, Djebrani-Oussedik N, Poujois A. New tools for Wilson’s disease diagnosis: exchangeable copper fraction. Ann Transl Med. 2019;7(Suppl 2):S70. doi:10.21037/atm.2019.03.02.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Annals of Innovation in Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.



